Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors.
Can Urol Assoc J
; 14(11): E582-E587, 2020 11.
Article
in En
| MEDLINE
| ID: mdl-32520703
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Can Urol Assoc J
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: